Research and Markets: Travel Vaccines Market to 2017 - Growth Is Attributable To an Increase in Outbound Travel and Increa

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/fbcdc2/travel_vaccines_ma) has announced the addition of the "Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market" report to their offering.

In 2010, the global travel vaccines market was estimated to be worth $2.7 billion, representing a Compound Annual Growth Rate (CAGR) of 11% between 2002 and 2010. By 2017, the global travel vaccines market is estimated to reach $6.6 billion, indicating a CAGR of 13% between 2010 and 2013. The growth of the travel vaccines market is attributable to an increase in outbound travel and increase in vaccination coverage due to increasing antimicrobial resistance and awareness about vaccine-preventable diseases such as hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis and meningococcal meningitis.

The target population base of the travel vaccines market includes outbound travelers. The vaccines used in the travel vaccines market for the prevention of hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis and meningococcal meningitis are manufactured by Sanofi Pasteur, Merck, Novartis, GlaxoSmithKline (GSK) and Intercell. Sanofi Pasteur and GSK are the leading players in the travel vaccines market. They generate 85% of the total travel vaccine revenues. Sanofi Pasteur manufactures vaccines for yellow fever, Japanese encephalitis, typhoid fever, rabies, and meningococcal meningitis therapeutics markets. GSK manufactures vaccines for hepatitis A and hepatitis B therapeutics markets.

The global travel vaccines market is expected to increase at a CAGR of 13% in the forecast period, from 2010 to 2017 because of the increase in outbound travel and increase in vaccination coverage due to increasing antimicrobial resistance and awareness about vaccine-preventable diseases.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by a team of industry experts.

Key Topics Covered:

  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Global Travel Vaccines Market to 2017- Introduction
  • 3 Global Travel Vaccines Market to 2017 - Market Overview
  • 4 Global Travel Vaccines Market to 2017 - Geographical Landscape
  • 5 Global Travel Vaccines Market to 2017 - Therapeutic Landscape
  • 6 Travel Vaccines Market - Product Pipeline Analysis
  • 7 Travel Vaccines Market - Competitive Landscape
  • 8 Travel Vaccines Market - M&A Landscape
  • 9 Travel Vaccines Market - Appendix

Companies Mentioned:

  • Sanofi Pasteur
  • GlaxoSmithKline plc
  • Merck & Co., Inc
  • Novartis AG
  • Intercell AG

For more information visit http://www.researchandmarkets.com/research/fbcdc2/travel_vaccines_ma.



CONTACT:

Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Travel  Other Travel  Pharmaceutical  Professional Services  Other Professional Services

MEDIA:

Logo
 Logo

Suggested Articles

Belén Garijo, currently CEO of Merck Healthcare, will succeed Stefan Oschmann as the German company's chief exec when his tenure ends in April 2021.

More than 60 researchers and bioethicists called on Pfizer to take time to collect more COVID-19 vaccine safety data, Bloomberg reports. 

Leaked details about an ad campaign to quell coronavirus fears before the election raise "every red flag I could dream of," an ex-HHS official said.